Related Experiment Video
Updated: Mar 17, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Shared and unique common genetic determinants between pediatric and adult celiac disease
Sabyasachi Senapati1,2, Ajit Sood3, Vandana Midha4
1Department of Genetics, University of Delhi South Campus, New Delhi, 110021, India.
Insights
Celiac disease (CD) in children and adults shares common genetic risk factors, suggesting they are part of the same disease spectrum. Further research is needed to explore novel genetic determinants and clinical heterogeneity.
Area of Science:
- Genetics and immunology
- Gastroenterology
- Pediatric and adult medicine
Background:
- Celiac disease (CD) is classified by age of onset: pediatric CD and adult CD.
- The genetic and phenotypic distinctions between pediatric and adult CD remain unclear.
- This study investigates shared genetic components in pediatric and adult CD within a North Indian cohort.
Purpose of the Study:
- To determine if pediatric and adult celiac disease are genetically and phenotypically distinct or represent a spectrum of the same condition.
- To explore common genetic underpinnings of celiac disease across different age groups.
- To identify shared and novel genetic risk determinants in pediatric and adult celiac disease.
Main Methods:
- Retrospective analysis of 531 pediatric and 871 adult CD patients (2001-2010).
- Genotyping using Immunochip for 217 pediatric CD, 340 adult CD patients, and 736 controls.
- Association analysis via logistic regression to identify susceptibility genetic variants.
Main Results:
- Classical CD was predominant in both pediatric and adult groups.
- Similarities were observed, with quantitative differences in female preponderance, presentation type, and autoimmune comorbidities.
- Shared HLA-DQ2 and -DQ8 haplotypes were major risk factors; ANK3 (rs4948256-A; rs10994257-T) was a suggestively associated non-HLA marker.
Conclusions:
- Pediatric and adult CD appear to be part of the same disease spectrum, supported by shared HLA risk alleles.
- Non-HLA genes may influence disease onset and extra-intestinal manifestations, requiring further functional investigation.
- This study provides the first comparative genetic analysis suggesting shared and novel risk determinants for CD across age groups.
Background:
Based on age of presentation, celiac disease (CD) is categorised as pediatric CD and adult CD. It however remains unclear if these are genetically and/or phenotypically distinct disorders or just different spectrum of the same disease. We therefore explored the common genetic components underlying pediatric and adult CD in a well characterized north Indian cohort.
Methods:
A retrospective analysis of children (n = 531) and adult (n = 871) patients with CD between January 2001 and December 2010 was done. The database included basic demographic characteristics, clinical presentations, associated diseases and complications, if any. The genotype dataset was acquired for children (n = 217) and adult CD patients (n = 340) and controls (n = 736) using Immunochip. Association analysis was performed using logistic regression model to identify susceptibility genetic variants.
Results:
The predominant form of CD was classical CD in both pediatric and adult CD groups. There was remarkable similarity between pediatric and adult CD except for quantitative differences between the two groups such as female preponderance, non-classical presentation, co-occurrence of other autoimmune diseases being more common amongst adult CD. Notably, same HLA-DQ2 and -DQ8 haplotypes were established as the major risk factors in both types of CD. In addition, a few suggestively associated (p < 5 × 10(-4)) non-HLA markers were identified of which only ANK3 (rs4948256-A; rs10994257-T) was found to be shared and explain risk for ~45 % of CD patients with HLA allele.
Discussion:
Overall phenotypic similarity between pediatric and adult CD groups can be explained by contribution of same HLA risk alleles. Different non-HLA genes/loci with minor risk seem to play crucial role in disease onset and extra intestinal manifestation of CD. None of the non-HLA risk variants reached genome-wide significance, however most of them were shown to have functional implication to disease pathogenesis. Functional relevance of our findings needs to be investigated to address clinical heterogeneity of CD.
Conclusions:
This present study is the first comparative study based on common genetic markers to suggest that CD in pediatric age group and in adults are the spectrum of the same disease with novel and shared genetic risk determinants. Follow-up fine mapping studies with larger study cohorts are warranted for further genetic investigation.
Related Concept Videos
Incomplete Dominance
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pedigree Analysis
Principles of Pharmacogenetics: Types of Genetic Variants

